Free Trial
OTCMKTS:BIOQ

Bioqual (BIOQ) Stock Price, News & Analysis

Bioqual logo
$67.50 0.00 (0.00%)
(As of 11/20/2024 ET)

About Bioqual Stock (OTCMKTS:BIOQ)

Key Stats

Today's Range
$67.50
$67.50
50-Day Range
$67.00
$70.00
52-Week Range
$59.00
$80.00
Volume
N/A
Average Volume
1 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
0.74%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

Receive BIOQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioqual and its competitors with MarketBeat's FREE daily newsletter.

BIOQ Stock News Headlines

BIOQUAL Declares Dividend
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
SEC rules Fox can skip vote on labeling TV opinion shows
BIOQUAL Presents Financial Results for Fiscal Year 2024
BIOQUAL, Inc. Announces a Reduction in Workforce
See More Headlines

BIOQ Stock Analysis - Frequently Asked Questions

Bioqual's stock was trading at $64.00 on January 1st, 2024. Since then, BIOQ shares have increased by 5.5% and is now trading at $67.50.
View the best growth stocks for 2024 here
.

Bioqual, Inc. (OTCMKTS:BIOQ) released its quarterly earnings data on Tuesday, October, 22nd. The company reported ($0.76) EPS for the quarter. The firm earned $11.77 million during the quarter. Bioqual had a negative trailing twelve-month return on equity of 2.85% and a negative net margin of 1.99%.

Shares of BIOQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioqual investors own include Zymergen (ZY), Allied Gaming & Entertainment (AGAE), Align Technology (ALGN), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO) and Berkeley Energia (BKY).

Company Calendar

Ex-Dividend for 10/28 Dividend
10/07/2024
Last Earnings
10/22/2024
Dividend Payable
10/28/2024
Today
11/21/2024
Fiscal Year End
5/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial physical research
Sub-Industry
Business Services
Current Symbol
OTCMKTS:BIOQ
CUSIP
09065J101
Fax
N/A
Employees
114
Year Founded
N/A

Profitability

Net Income
$480,000.00
Pretax Margin
0.81%

Debt

Sales & Book Value

Annual Sales
$58.59 million
Cash Flow
$15.00 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.33
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:BIOQ) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners